Recently announced intent to rename and rebrand to Lifecore Biomedical, along with leadership and Board changes Lifecore segment revenues increased 6.9% to $27.6 million in fiscal fourth quarter, and increased 11.5% to $109.3 million for the full fiscal year 2022, as compared to the respective
Landec expected to rename and rebrand to Lifecore Biomedical and update Nasdaq ticker symbol Names new CEO Announces future changes to its Board of Directors SANTA MARIA, Calif. and MINNEAPOLIS, Minn. , Aug. 10, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”),
SANTA MARIA, Calif. , July 27, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its growing Lifecore Biomedical (“Lifecore”) business – a fully integrated contract development and manufacturing organization
BreatheWay divestment represents another step towards creating a CDMO-focused company aligned with attractive growth categories and end markets SANTA MARIA, Calif. , June 02, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness
Lifecore segment revenues increased 27.9% in fiscal third quarter, as compared to prior year period Reiterates fiscal 2022 full year guidance SANTA MARIA, Calif. , April 05, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness
SANTA MARIA, Calif. , March 22, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its growing Lifecore Biomedical (“Lifecore”) business – a fully integrated contract development and manufacturing organization
SANTA MARIA, Calif. , Jan. 07, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its growing Lifecore Biomedical (“Lifecore”) business – a fully integrated contract development and manufacturing organization
Reiterates Fiscal 2022 Guidance for Lifecore Provides Pro Forma Curation Foods Segment Results and Updates Guidance for Continuing Segment Operations SANTA MARIA, Calif. , Jan. 05, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and
Strategic sale results in a CDMO-focused company aligned with attractive growth categories and end markets Net proceeds from the sale will be allocated towards debt pay down, resulting in significant deleveraging Announces fiscal second quarter earnings call on January 5, 2022 SANTA MARIA, Calif.
Quarterly net loss of $9.5 million , EBITDA of $1.1 million , and Adjusted EBITDA of $4.4 million Reiterates Fiscal Year 2022 Guidance SANTA MARIA, Calif. , Sept. 29, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses,